IDH2 is a novel diagnostic and prognostic serum biomarker for non‐small‐cell lung cancer

Lung cancer is the most common leading cause of cancer‐related death worldwide. Late diagnosis contributes to a high mortality rate and poor survival of this cancer. In our previous study, we found that IDH2 polymorphism rs11540478 is a risk factor for lung cancer. Here, we examined IDH2 protein exp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Li, Jiang‐jiang, Li, Ruilei, Wang, Wenxiang, Zhang, Baihua, Song, Xin, Zhang, Chunfang, Gao, Yang, Liao, Qianjin, He, Ya, You, Shuo, Tan, Zheqiong, Luo, Xiangjian, Li, Yueshuo, Tang, Min, Weng, Xinxian, Yi, Wei, Peng, Shifang, Liu, Shaohui, Tan, Ying, Bode, Ann M., Cao, Ya
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928355/
https://ncbi.nlm.nih.gov/pubmed/29465809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12182
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados